{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:38:56Z","timestamp":1769117936978,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.anpedi.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T18:23:10Z","timestamp":1550254990000},"page":"256-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lesi\u00f3n hep\u00e1tica inducida por quimioterapia en ni\u00f1os"],"prefix":"10.1016","volume":"91","author":[{"given":"Emilia","family":"Urrutia-Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Abril-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Al\u00e9s-Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mar\u00eda","family":"G\u00f3mez-Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Mu\u00f1oz de Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Ocete-Hita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2019.01.003_bib0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2013.07.010","article-title":"Chemotherapy-induced hepatotoxicity","volume":"17","author":"Thatishetty","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2016.1194824","article-title":"Drug-induced hepatotoxicity in cancer patients \u2014implication for treatment","volume":"15","author":"Vincenzi","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminhematol.2008.09.007","article-title":"Treatment of childhood acute lymphoblastic leukemia","volume":"46","author":"Stanulla","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anpedi.2016.05.007","article-title":"La oncolog\u00eda pedi\u00e1trica: pasado, presente y futuro","volume":"85","author":"Fern\u00e1ndez-Delgado","year":"2016","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0135","doi-asserted-by":"crossref","first-page":"e26891","DOI":"10.1002\/pbc.26891","article-title":"Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens","volume":"65","author":"Denton","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.anpedi.2019.01.003_bib0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anpedi.2014.09.005","article-title":"Linfoma no Hodgkin: excelentes resultados a expensas de elevada toxicidad del tratamiento","volume":"82","author":"Baena-G\u00f3mez","year":"2015","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: Clinical facts and fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.anpedi.2012.06.012","article-title":"Hepatotoxicity due to drugs or natural products in children","volume":"78","author":"Ocete Hita","year":"2013","journal-title":"An Pediatr"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0155","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0160","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1208\/s12248-013-9489-z","article-title":"Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients","volume":"15","author":"Barrett","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-Induced Liver Injury Network (DILIN) prospective study: Rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.anpedi.2019.01.003_bib0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: Interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MOG.0b013e3283383c7c","article-title":"Drug-induced liver injury: A clinical update","volume":"26","author":"Ghabril","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.29152","article-title":"Drug rechallenge following drug-induced liver injury","volume":"66","author":"Hunt","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2015.12.017","article-title":"Adverse drug reactions and organ damage: The liver","volume":"28","author":"Licata","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0205","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1158\/1078-0432.CCR-16-0449","article-title":"The effect of hepatic impairment on outcomes in phase i. Clinical trials in cancer subjects","volume":"22","author":"Mansfield","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of chemotherapy","volume":"33","author":"Floyd","year":"2006","journal-title":"Seminars in Oncology"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0192623309351719","article-title":"Unintended hepatic adverse events associated with cancer chemotherapy","volume":"38","author":"Senior","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.anpedi.2019.01.003_bib0220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pds.3405","article-title":"A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data","volume":"22","author":"Parks","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403319300177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403319300177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:49:01Z","timestamp":1761662941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403319300177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1695403319300177"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.01.003","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lesi\u00f3n hep\u00e1tica inducida por quimioterapia en ni\u00f1os","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda.","name":"copyright","label":"Copyright"}]}}